Judy Ho

13.7k total citations · 1 hit paper
26 papers, 1.4k citations indexed

About

Judy Ho is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Judy Ho has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 7 papers in Surgery. Recurrent topics in Judy Ho's work include Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Screening and Detection (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Judy Ho is often cited by papers focused on Genetic factors in colorectal cancer (10 papers), Colorectal Cancer Screening and Detection (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Judy Ho collaborates with scholars based in China, Hong Kong and United States. Judy Ho's co-authors include Sharon H. S. Lam, Antoinette M. Lee, Ivy P. F. Leung, Ester Cerin, Wynnie Chan, Bryant P. H. Hui, Kar Keung Cheng, Dyt Fong, Duncan J. Macfarlane and Ssf Leung and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Judy Ho

25 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Physical activity for cancer survivors: meta-analysis of randomised controlled trials

2012 591 citations Dyt Fong, Judy Ho et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judy Ho China	15	994	363	302	267	234	26	1.4k
Aart van Bochove Netherlands	16	1.3k 1.3×	209 0.6×	464 1.5×	196 0.7×	129 0.6×	32	1.6k
Anthony Fields Canada	22	2.0k 2.0×	289 0.8×	570 1.9×	374 1.4×	345 1.5×	45	2.7k
Halle C. F. Moore United States	22	1.0k 1.0×	210 0.6×	415 1.4×	113 0.4×	107 0.5×	88	1.6k
Michael P. Thirlwell Canada	19	501 0.5×	119 0.3×	301 1.0×	144 0.5×	139 0.6×	42	1.2k
Jarley Koo Canada	19	1.2k 1.2×	289 0.8×	249 0.8×	113 0.4×	340 1.5×	29	2.1k
Louise Bordeleau Canada	24	1.0k 1.0×	145 0.4×	412 1.4×	182 0.7×	64 0.3×	66	1.9k
Richard Eastell United Kingdom	18	788 0.8×	213 0.6×	97 0.3×	223 0.8×	98 0.4×	29	2.0k
Tracey L. O’Connor United States	17	944 0.9×	137 0.4×	332 1.1×	188 0.7×	77 0.3×	59	1.4k
Nicky Hood Canada	15	1.6k 1.6×	326 0.9×	261 0.9×	194 0.7×	348 1.5×	20	2.4k
Gillian Libby United Kingdom	19	1.1k 1.1×	216 0.6×	462 1.5×	139 0.5×	61 0.3×	38	2.1k

Countries citing papers authored by Judy Ho

Since Specialization

Citations

This map shows the geographic impact of Judy Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judy Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judy Ho more than expected).

Fields of papers citing papers by Judy Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judy Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judy Ho. The network helps show where Judy Ho may publish in the future.

Co-authorship network of co-authors of Judy Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Judy Ho. A scholar is included among the top collaborators of Judy Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judy Ho. Judy Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mascarenhas, John, Salman Otoukesh, Terrence Bradley, et al.. (2024). Trial Update from IMproveMF, an Ongoing, Open-Label, Dose-Escalation and -Expansion, Phase 1/1B Trial to Evaluate the Safety, Pharmacokinetics, and Clinical Activity of the Novel Combination of Imetelstat with Ruxolitinib in Patients with Intermediate-1, Intermediate-2, or High-Risk Myelofibrosis (MF). Blood. 144(Supplement 1). 998–998. 1 indexed citations

Mascarenhas, John, Claire Harrison, Prithviraj Bose, et al.. (2024). Imetelstat Versus Best Available Therapy in Patients with Intermediate-2 or High-Risk Myelofibrosis Relapsed or Refractory to Janus Kinase Inhibitor in IMpactMF, a Randomized, Open-Label, Phase 3 Trial. Blood. 144(Supplement 1). 1808.1–1808.1. 3 indexed citations

Kuykendall, Andrew, Terrence Bradley, Rami S. Komrokji, et al.. (2023). PB2221: AN OPEN-LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS: IMPROVEMF. HemaSphere. 7(S3). e906057e–e906057e. 1 indexed citations

Mascarenhas, John, Claire Harrison, Jean‐Jacques Kiladjian, et al.. (2023). PB2225: A RANDOMIZED OPEN-LABEL, PHASE 3 STUDY OF IMETELSTAT VS BEST AVAILABLE THERAPY IN INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS RELAPSED/REFRACTORY TO JAK INHIBITOR (IMPACTMF). HemaSphere. 7(S3). e99899f4–e99899f4. 1 indexed citations

Lee, Adam, et al.. (2016). Juvenile Polyposis coli in a 9 year old boy. 7(1). 47–51. 1 indexed citations

Ke, Liang, et al.. (2014). Prevalence, Awareness, Treatment and Control of Hypertension in Macau: Results From a Cross-Sectional Epidemiological Study in Macau, China. American Journal of Hypertension. 28(2). 159–165. 36 indexed citations

Ho, Judy, et al.. (2014). Malnutrition risk predicts surgical outcomes in patients undergoing gastrointestinal operations: Results of a prospective study. Clinical Nutrition. 34(4). 679–684. 74 indexed citations

Brown, Matthew S., Hyun J. Kim, Martin Allen-Auerbach, et al.. (2012). Computer-aided quantitative bone scan assessment of prostate cancer treatment response. Nuclear Medicine Communications. 33(4). 384–394. 36 indexed citations

Fong, Dyt, Judy Ho, Bryant P. H. Hui, et al.. (2012). Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 344(jan30 5). e70–e70. 591 indexed citations breakdown →

10.

Choi, Chang‐In, Stewart Y. Tung, Louis Tak Lui, et al.. (2007). Efficacy of Combination Chemotherapy with Irinotecan (CPT-11) plus Capecitabine in Patients with Metastatic or Advanced Colorectal Carcinoma — a Dual-centre Phase II Study: the MAC-6. Clinical Oncology. 20(2). 168–175. 7 indexed citations

11.

Law, Wai Lun, Judy Ho, Raymond J. Chan, Gordon K.�H. Au, & Kin Wah Chu. (2005). Outcome of Anterior Resection for Stage II Rectal Cancer Without Radiation: The Role of Adjuvant Chemotherapy. Diseases of the Colon & Rectum. 48(2). 218–226. 26 indexed citations

12.

Law, Wai‐Lun, et al.. (2004). Bowel Preparation for Colonoscopy: A Randomized Controlled Trial Comparing Polyethylene Glycol Solution, One Dose and Two Doses of Oral Sodium Phosphate Solution. Asian Journal of Surgery. 27(2). 120–124. 36 indexed citations

13.

Chan, Tsun Leung, Judy Ho, Annie S Y Chan, et al.. (2004). MSH2 c.1452–1455delAATG Is a Founder Mutation and an Important Cause of Hereditary Nonpolyposis Colorectal Cancer in the Southern Chinese Population. The American Journal of Human Genetics. 74(5). 1035–1042. 30 indexed citations

14.

Wong, Wai Man, Shiu Kum Lam, Paul Rozen, et al.. (2003). Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population. Cancer. 97(10). 2420–2424. 44 indexed citations

15.

Chan, Tsun Leung, Judy Ho, Annie S Y Chan, et al.. (2001). A novel germline 1.8-kb deletion of hMLH1 mimicking alternative splicing: a founder mutation in the Chinese population. Oncogene. 20(23). 2976–2981. 33 indexed citations

16.

Au, G.K.H., et al.. (2001). Radiation Recall with Oxaliplatin: Report of a Case and a Review of the Literture. Clinical Oncology. 13(1). 55–57. 14 indexed citations

17.

Ho, Judy, Siu–Tsan Yuen, Lap-Ping Chung, et al.. (2000). Distinct clinical features associated with microsatellite instability in colorectal cancers of young patients. International Journal of Cancer. 89(4). 356–360. 22 indexed citations

18.

Ho, Judy, et al.. (1999). THE ROLE OF SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS PATIENTS WITH ILEAL POUCH POLYPOSIS. Australian and New Zealand Journal of Surgery. 69(10). 756–758. 4 indexed citations

19.

Ho, Judy, et al.. (1999). Helicobacter pylori in Meckel’s diverticulum with heterotopic gastric mucosa in a population with relatively high H. pylori prevalence rate. Journal of Gastroenterology and Hepatology. 14(4). 313–316. 16 indexed citations

20.

Chan, Tzu-Liang, ST Yuen, Leland W.K. Chung, et al.. (1999). Frequent Microsatellite Instability and Mismatch Repair Gene Mutations in Young Chinese Patients With Colorectal Cancer. JNCI Journal of the National Cancer Institute. 91(14). 1221–1226. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact